Buy & Sell Vertex Pharmaceuticals Incorporated (VRTX) – Vertex Pharmaceuticals Incorporated Price Today
Key Stats
- $108.72BMarket Cap
- HealthSector
- -15.21%3M Drawdown
- $103.45BEnterprise Value
- -Dividend Yield
- 9% Buy | 91% SellTrading Activity
- 103 daysTypical Hold Time
Vertex Pharmaceuticals Incorporated (VRTX) is currently valued at a market capitalization of $108.72B, with an enterprise value of $103.45B. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $366.54 and a high of $499.17, highlighting its annual price range. Over the past three months, Vertex Pharmaceuticals Incorporated has recorded a drawdown of -15.21%, reflecting recent price volatility. On average, investors hold Vertex Pharmaceuticals Incorporated for approximately 103 days, indicating typical investor behavior on the platform.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
Tianjin Shipping Expo spotlights AI's growing role in transforming global shipping and port operations.
The 4th Tianjin International Shipping Industry Expo highlighted the expanding use of AI in the shipping sector, focusing on innovations like automated container terminals and intelligent logistics. Industry leaders emphasized AI's potential to enhan...
Cloudera adopts Apache Polaris to enhance secure, governed AI data access across hybrid and multi-cloud environments.
Cloudera announced its adoption of Apache Polaris, an open-source catalog based on Apache Iceberg, to improve interoperability and governance for enterprise AI data access. This integration aims to help companies securely share and manage data across...
Cloudera adopts Apache Polaris to enhance secure, governed AI data access across hybrid and multi-cloud environments.
Cloudera announced the adoption of Apache Polaris as part of its open data lakehouse architecture to improve interoperability and governed access to enterprise data regardless of storage location. This integration addresses challenges like data fragm...